[EN] AMINOHETEROARYL KINASE INHIBITORS<br/>[FR] INHIBITEURS DE KINASES DE TYPE AMINOHÉTÉROARYLE
申请人:ANRUI BIOMEDICAL TECH GUANGZHOU CO LTD
公开号:WO2022111621A1
公开(公告)日:2022-06-02
Provided herein are novel compounds (e.g., Formula I or II), pharmaceutical compositions, and methods of using related to cyclin dependent kinases (CDKs). The compounds herein are typically CDK2 inhibitors, which can be used for treating a variety of diseases or disorders, such as cancer.
本文提供了新型化合物(例如,公式I或II),制药组合物和使用方法,涉及到细胞周期蛋白依赖性激酶(CDKs)。这些化合物通常是CDK2抑制剂,可用于治疗各种疾病或障碍,例如癌症。